Evidence map›Paper›PMID 35972812›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2023

Reply to 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity' by R. Molinier et al.

Angelo Ruggiero, Fabrizio Martora, Fabrizio Fornaro, Massimiliano Scalvenzi, Gabriella Fabbrocini, Alessia Villani

Abstract readLetterComment
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022
    Review
  4. The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.Clinical, cosmetic and investigational dermatology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Angelo RuggieroSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.ORCID 0000-0002-4658-7391
Fabrizio MartoraSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.ORCID 0000-0003-2523-050X
Fabrizio FornaroSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Massimiliano ScalvenziSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Gabriella FabbrociniSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Alessia VillaniSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.ORCID 0000-0001-6430-268X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19MelanomaCommunicable Disease ControlHumansPandemicsSARS-CoV-2

Identifiers

PMID35972812
PMCPMC9538296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.